Your browser doesn't support javascript.
loading
Comprehensive Prostate Fluid-Based Spectral Libraries for Enhanced Protein Detection in Urine.
Ha, Annie; Khoo, Amanda; Ignatchenko, Vladimir; Khan, Shahbaz; Waas, Matthew; Vesprini, Danny; Liu, Stanley K; Nyalwidhe, Julius O; Semmes, Oliver John; Boutros, Paul C; Kislinger, Thomas.
Afiliación
  • Ha A; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
  • Khoo A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Ignatchenko V; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
  • Khan S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Waas M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Vesprini D; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Liu SK; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada.
  • Nyalwidhe JO; Department of Radiation Oncology, University of Toronto, Toronto, Ontario M5T 1P5, Canada.
  • Semmes OJ; Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Ontario M4N 3M5, Canada.
  • Boutros PC; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
  • Kislinger T; Department of Radiation Oncology, University of Toronto, Toronto, Ontario M5T 1P5, Canada.
J Proteome Res ; 23(5): 1768-1778, 2024 May 03.
Article en En | MEDLINE | ID: mdl-38580319
ABSTRACT
Biofluids contain molecules in circulation and from nearby organs that can be indicative of disease states. Characterizing the proteome of biofluids with DIA-MS is an emerging area of interest for biomarker discovery; yet, there is limited consensus on DIA-MS data analysis approaches for analyzing large numbers of biofluids. To evaluate various DIA-MS workflows, we collected urine from a clinically heterogeneous cohort of prostate cancer patients and acquired data in DDA and DIA scan modes. We then searched the DIA data against urine spectral libraries generated using common library generation approaches or a library-free method. We show that DIA-MS doubles the sample throughput compared to standard DDA-MS with minimal losses to peptide detection. We further demonstrate that using a sample-specific spectral library generated from individual urines maximizes peptide detection compared to a library-free approach, a pan-human library, or libraries generated from pooled, fractionated urines. Adding urine subproteomes, such as the urinary extracellular vesicular proteome, to the urine spectral library further improves the detection of prostate proteins in unfractionated urine. Altogether, we present an optimized DIA-MS workflow and provide several high-quality, comprehensive prostate cancer urine spectral libraries that can streamline future biomarker discovery studies of prostate cancer using DIA-MS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteoma / Proteómica Límite: Humans / Male Idioma: En Revista: J Proteome Res Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteoma / Proteómica Límite: Humans / Male Idioma: En Revista: J Proteome Res Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Canadá